Drug Type ASO |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization SpliSense Ltd.Startup |
Active Organization SpliSense Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | IL | SpliSense Ltd.Startup | - |
Bronchiectasis | Preclinical | IL | SpliSense Ltd.Startup | - |
Pulmonary Disease, Chronic Obstructive | Preclinical | IL | SpliSense Ltd.Startup | - |
Cystic Fibrosis | Discovery | IL | SpliSense Ltd.Startup | - |
Kartagener Syndrome | Discovery | IL | SpliSense Ltd.Startup | - |
Pulmonary Fibrosis | Discovery | IL | SpliSense Ltd.Startup | - |